Ignite Creation Date:
2024-05-06 @ 1:21 PM
Last Modification Date:
2024-10-26 @ 1:13 PM
Study NCT ID:
NCT04009317
Status:
UNKNOWN
Last Update Posted:
2019-10-30
First Post:
2019-07-02
Brief Title:
Study of TQ-B3139 Versus Crizotinib in the First Line Treatment of Subjects With Anaplastic Lymphoma Kinase ALK Positive Non-Small Cell Lung Cancer NSCLC
Sponsor:
Organization:
Chia Tai Tianqing Pharmaceutical Group Co Ltd